| Literature DB >> 20049159 |
S Karami1, P Brennan, M Navratilova, D Mates, D Zaridze, V Janout, H Kollarova, V Bencko, V Matveev, N Szesznia-Dabrowska, I Holcatova, M Yeager, S Chanock, N Rothman, P Boffetta, W-H Chow, L E Moore.
Abstract
Mediated by binding to the high-affinity vitamin D receptor (VDR), vitamin D forms a heterodimer complex with the retinoid-X-receptor (RXR). Variation in both genes has been shown to modify renal cell carcinoma (RCC) risk. Therefore, we investigated whether VDR and RXRA polymorphisms modify associations between RCC risk and frequency of dietary intake of vitamin D and calcium rich foods, and occupational ultraviolet exposure among 777 RCC case and 1035 controls from Central and Eastern Europe. A positive association was observed in this population between increasing dietary intake frequency of yogurt, while an inverse association was observed with egg intake frequency. RXRA polymorphisms, located 3' of the coding sequence, modified associations between specific vitamin D rich foods and RCC risk, while RXRA polymorphisms, located in introns 1 and 4, modified associations with specific calcium rich foods. Results suggest that variants in the RXRA gene modified the associations observed between RCC risk and calcium and vitamin D intake.Entities:
Year: 2009 PMID: 20049159 PMCID: PMC2798114 DOI: 10.1155/2010/879362
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
General characteristics of genotyped participants.
| Genotyped participants | |||||
|---|---|---|---|---|---|
| Variables | Cases | Controls | |||
|
| |||||
| N | % | N | % |
†
| |
|
| |||||
| Participants | 777 | 42.9 | 1,035 | 57.1 | |
| Sex | |||||
| Males | 472 | 60.7 | 648 | 62.6 | |
| Females | 305 | 39.3 | 387 | 37.4 | .42 |
| Age at Interview | |||||
| <45 | 60 | 7.7 | 83 | 8.0 | |
| 45–54 | 197 | 25.4 | 287 | 27.7 | |
| 55–64 | 243 | 31.3 | 309 | 29.9 | |
| 65–74 | 242 | 31.1 | 318 | 30.7 | |
| 75+ | 35 | 4.5 | 38 | 3.7 | .30 |
|
| |||||
| Mean age (std) | 59.5 years (10.4) | 59.0 years (10.2) | |||
|
| |||||
| Center | |||||
| Romania-Bucharest | 68 | 8.8 | 94 | 9.1 | |
| Poland-Lodz | 80 | 10.3 | 189 | 18.3 | |
| Russia-Moscow | 242 | 31.1 | 313 | 30.2 | |
| *Czech Republic | 387 | 49.8 | 439 | 42.4 | <.001 |
| BMI at Interview | |||||
| <25 | 222 | 28.6 | 375 | 36.3 | |
| 25–29.9 | 330 | 42.5 | 432 | 41.9 | |
| 30+ | 225 | 29.0 | 225 | 21.8 | <.001 |
| Tobacco status | |||||
| Never | 359 | 46.4 | 420 | 40.7 | |
| Ever | 415 | 53.6 | 613 | 59.3 | .02 |
| Hypertension | |||||
| No | 434 | 55.9 | 638 | 61.7 | |
| Yes | 342 | 44.1 | 396 | 38.3 | .01 |
| Familial history of cancer Among 1st degree relatives | |||||
| No | 512 | 65.9 | 745 | 72.0 | |
| Yes | 265 | 34.1 | 290 | 28.0 | .01 |
* Brno, Olomouc, Prague, Ceske-Budejovice; †Crude P-values.
RCC risk by dietary intake frequency of vitamin D and calcium rich foods among genotyped participants.
| Cases | Controls | Adjusted | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Intake Frequency | N | % | N | % | OR | UCI | — | LCI |
|
|
| |||||||||
| Liver | |||||||||
| Low (<33%) | 318 | 41.0 | 411 | 39.7 | 1.00 | ||||
| Medium (33–66%) | 315 | 40.6 | 380 | 36.7 | 1.11 | 0.89 | — | 1.38 | |
| High (>66%) | 143 | 18.4 | 244 | 23.6 | 0.82 | 0.63 | — | 1.07 | .28 |
| Egg | |||||||||
| Low (<33%) | 274 | 35.3 | 345 | 33.3 | 1.00 | ||||
| Medium (33–66%) | 392 | 50.5 | 454 | 43.9 | 1.11 | 0.90 | — | 1.38 | |
| High (>66%) | 110 | 14.2 | 236 | 22.8 | 0.64 | 0.48 | — | 0.86 |
|
| Fresh Water Fish | |||||||||
| Low (<33%) | 260 | 33.5 | 345 | 33.3 | 1.00 | ||||
| Medium (33–66%) | 274 | 35.3 | 344 | 33.2 | 1.06 | 0.84 | — | 1.34 | |
| High (>66%) | 242 | 31.2 | 346 | 33.4 | 0.94 | 0.74 | — | 1.19 | .60 |
| Salt Water Fish | |||||||||
| Low (<33%) | 259 | 33.4 | 346 | 33.4 | 1.00 | ||||
| Medium (33–66%) | 334 | 43.0 | 419 | 40.5 | 1.02 | 0.82 | — | 1.27 | |
| High (>66%) | 183 | 23.6 | 270 | 26.1 | 0.91 | 0.71 | — | 1.18 | .53 |
| Total Fish | |||||||||
| Low (<33%) | 290 | 37.4 | 380 | 36.7 | 1.00 | ||||
| Medium (33–66%) | 236 | 30.4 | 309 | 29.9 | 0.98 | 0.77 | — | 1.23 | |
| High (>66%) | 250 | 32.2 | 346 | 33.4 | 0.95 | 0.75 | — | 1.19 | .65 |
| ^Total Vitamin D | |||||||||
| Low (<33%) | 284 | 36.6 | 345 | 33.3 | 1.00 | ||||
| Medium (33–66%) | 279 | 36.0 | 353 | 34.1 | 0.95 | 0.76 | — | 1.20 | |
| High (>66%) | 213 | 27.4 | 337 | 32.6 | 0.81 | 0.63 | — | 1.03 | .09 |
| Cheese | |||||||||
| Low (<33%) | 193 | 24.9 | 286 | 27.6 | 1.00 | ||||
| Medium (33–66%) | 302 | 38.9 | 337 | 32.6 | 1.31 | 1.03 | — | 1.68 | |
| High (>66%) | 281 | 36.2 | 412 | 39.8 | 0.99 | 0.77 | — | 1.26 | .71 |
| Yogurt | |||||||||
| Low (<33%) | 202 | 26.0 | 347 | 33.5 | 1.00 | ||||
| Medium (33–66%) | 278 | 35.8 | 313 | 30.2 | 1.48 | 1.16 | — | 1.88 | |
| High (>66%) | 296 | 38.1 | 375 | 36.2 | 1.31 | 1.03 | — | 1.67 |
|
| Milk | |||||||||
| Low (<33%) | 179 | 23.1 | 264 | 25.5 | 1.00 | ||||
| Medium (33–66%) | 292 | 37.6 | 389 | 37.6 | 1.10 | 0.86 | — | 1.42 | |
| High (>66%) | 305 | 39.3 | 382 | 36.9 | 1.14 | 0.89 | — | 1.46 | .31 |
| *Total Calcium | |||||||||
| Low (<33%) | 226 | 29.1 | 345 | 33.3 | 1.00 | ||||
| Medium (33–66%) | 274 | 35.3 | 355 | 34.3 | 1.16 | 0.91 | — | 1.48 | |
| High (>66%) | 276 | 35.6 | 335 | 32.4 | 1.20 | 0.92 | — | 1.58 | .18 |
All values adjusted for sex, age, study center, self-reported hypertensive status, BMI, and smoking status.
Frequency of dietary intake variables categorized into tertiles based on intake among genotypes controls.
^Total Vitamin D (L, M, H) variable based on liver, egg, and salt and fresh water fish consumption.
^Also adjusted for years of occupational UV exposure.
* Total calcium variable based on cheese, yogurt, and milk consumption.
RXRA SNPs modify associations between dietary intake frequency of vitamin D rich foods and risk of renal cell carcinoma.
| Genotype association | §Dietary intake of egg | †Dietary intake of vitamin D rich foods | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wild type | ≥1 variant | Wild type | ≥1 variant | ||||||||||||||||
|
| |||||||||||||||||||
| Cases/Controls | Cases/Controls | Cases/Controls | Cases/Controls | Cases/Controls | |||||||||||||||
|
| |||||||||||||||||||
| SNP | N/N | OR | (LCI-UCI) | Egg | N/N | OR | (LCI-UCI) | N/N | OR | (LCI-UCI) | *LRT | Vitamin D | N/N | OR | (LCI-UCI) | N/N | OR | (LCI-UCI) | *LRT |
|
| |||||||||||||||||||
| rs1007971 (*7453G > | Dietary intake of egg | Dietary intake of vitamin D rich foods | |||||||||||||||||
|
| |||||||||||||||||||
| CG/CC | 293/338 | 1.00 | Low (<33%) | 153/231 | 1.00 | 119/107 | 1.00 | Low (<33%) | 171/234 | 1.00 | 113/111 | 1.00 | |||||||
| GG | 484/697 | 0.79 | (0.64–0.96) | Medium (33–66%) | 251/328 | 1.27 | (0.95–1.69) | 143/133 | 1.05 | (0.71–1.54) | Medium (33–66%) | 164/239 | 0.90 | (0.67–1.20) | 115/114 | 1.04 | (0.70–1.55) | ||
| High (>66%) | 79/138 | 0.99 | (0.69–1.43) | 31/98 | 0.32 | (0.19–0.53) | High (>66%) | 148/224 | 0.90 | (0.66–1.25) | 65/113 | 0.63 | (0.39–1.00) | ||||||
|
^
|
|
|
| < |
|
|
|
| 0.11 | ||||||||||
|
| |||||||||||||||||||
| rs3118523 (*7060A > | Dietary intake of Egg | Dietary intake of vitamin D rich foods | |||||||||||||||||
|
| |||||||||||||||||||
| AG/GG | 295/321 | 1.00 | Low (<33%) | 149/237 | 1.00 | 123/101 | 1.00 | Low (<33%) | 174/233 | 1.00 | 110/112 | 1.00 | |||||||
| AA | 482/714 | 0.72 | (0.58–0.88) | Medium (33–66%) | 253/331 | 1.34 | (1.01–1.80) | 141/130 | 0.95 | (0.64–1.40) | Medium (33–66%) | 165/246 | 0.87 | (0.65–1.16) | 114/107 | 1.13 | (0.75–1.68) | ||
| High (>66%) | 79/146 | 0.98 | (0.68–1.42) | 31/90 | 0.29 | (0.17–0.49) | High (>66%) | 142/235 | 0.78 | (0.57–1.08) | 71/102 | 0.86 | (0.54–1.38) | ||||||
|
^
|
|
|
| < |
|
|
|
| .59 | ||||||||||
|
| |||||||||||||||||||
| rs748964 (*5628C > | Dietary intake of egg | Dietary intake of vitamin D rich foods | |||||||||||||||||
|
| |||||||||||||||||||
| CG/GG | 214/224 | 1.00 | Low (<33%) | 180/270 | 1.00 | 92/68 | 1.00 | Low (<33%) | 207/277 | 1.00 | 77/68 | 1.00 | |||||||
| CC | 563/811 | 0.70 | (056–0.88) | Medium (33–66%) | 291/367 | 1.26 | (0.97–1.64) | 103/94 | 0.91 | (0.56–1.46) | Medium (33–66%) | 193/263 | 0.97 | (0.74–1.27) | 86/90 | 0.83 | (0.52–1.35) | ||
| High (>66%) | 91/174 | 0.86 | (0.62–1.20) | 19/62 | 0.21 | (0.11–0.42) | High (>66%) | 162/271 | 0.82 | (0.61–1.11) | 51/66 | 0.69 | (0.39–1.24) | ||||||
|
^
|
|
|
| < |
|
|
|
| .72 | ||||||||||
|
| |||||||||||||||||||
| rs3118536 (IVS4-542C > A) | Dietary intake of egg | Dietary intake of vitamin D rich foods | |||||||||||||||||
|
| |||||||||||||||||||
| AC/AA | 259/310 | 1.00 | Low (<33%) | 175/250 | 1.00 | 97/88 | 1.00 | Low (<33%) | 195/248 | 1.00 | 89/97 | 1.00 | |||||||
| CC | 518/725 | 0.82 | (0.67–1.00) | Medium (33–66%) | 263/320 | 1.25 | (0.95–1.65) | 131/141 | 0.90 | (0.59–1.37) | Medium (33–66%) | 168/235 | 0.91 | (0.68–1.21) | 111/118 | 0.96 | (0.64–1.44) | ||
| High (>66%) | 79/155 | 0.81 | (0.57–1.16) | 31/81 | 0.35 | (0.20–0.60) | High (>66%) | 154/242 | 0.86 | (0.63–1.17) | 59/95 | 0.65 | (0.40–1.06) | ||||||
|
^
|
|
|
| < | .21 |
|
|
| .99 | ||||||||||
|
| |||||||||||||||||||
| rs10776909 (IVS1-4732C > T) | Dietary intake of egg | Dietary intake of vitamin D rich foods | |||||||||||||||||
|
| |||||||||||||||||||
| CT/TT | 302/372 | 1.00 | Low (<33%) | 159/227 | 1.00 | 113/111 | 1.00 | Low (<33%) | 174/226 | 1.00 | 110/119 | 1.00 | |||||||
| CC | 475/663 | 0.86 | (0.70–1.04) | Medium (33–66%) | 242/291 | 1.24 | (0.93–1.67) | 152/170 | 1.00 | (0.69–1.46) | Medium (33–66%) | 155/205 | 1.00 | (0.74–1.36) | 124/148 | 0.84 | (0.58–1.21) | ||
| High (>66%) | 73/145 | 0.78 | (0.54–1.13) | 37/91 | 0.44 | (0.26–0.72) | High (>66%) | 145/232 | 0.88 | ( 0.63–1.22) | 68/105 | 0.65 | (0.41–1.02) | ||||||
|
^
|
|
|
|
| .37 |
|
|
| .82 | ||||||||||
Main effects adjusted for age, sex, study center, and smoking status.
Frequency of dietary intake variables categorized into tertiles based on intake among genotyped controls.
§ Dietary effect adjusted for age, study center, BMI, self-reported hypertensive status, and smoking status.
† Dietary effect adjusted for age, study center, BMI, self-reported hypertensive status, smoking status, and occupational UV exposure.
^ P-trend based on additive model. * Likelihood Ratio Test.
Effect of RXRA SNPs on dietary intake frequency of calcium rich foods and risk of renal cell carcinoma.
| rs3118538 (IVS4-542C > A) | rs10776909 (IVS1-4732C > T) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wild type | ≥1 variant | Wild type | ≥1 variant | |||||||||||
|
| ||||||||||||||
| Cases/Controls | Cases/Controls | Cases/Controls | Cases/Controls | |||||||||||
|
| ||||||||||||||
| N/N | OR | (UCI-LCI) | N/N | OR | (UCI-LCI) | *LRT | N/N | OR | (UCI-LCI) | N/N | OR | (UCI-LCI) | *LRT | |
|
| ||||||||||||||
| Dietary Intake of Yogurt | ||||||||||||||
| Low (<33%) | 133/266 | 1.00 | 77/91 | 1.00 | 123/247 | 1.00 | 87/110 | 1.00 | ||||||
| Medium (33–66%) | 185/212 | 1.88 | (1.34–2.64) | 85/91 | 1.23 | (0.73–2.08) | 169/198 | 1.84 | (1.29–2.63) | 101/105 | 1.29 | (0.81–2.07) | ||
| High (>66%) | 199/247 | 1.69 | (1.18–2.42) | 97/128 | 0.87 | (0.51–1.50) | 182/218 | 1.71 | (1.18–2.49) | 114/157 | 0.94 | (0.58–1.54) | ||
|
|
|
|
|
| ||||||||||
| .09 | . | |||||||||||||
|
| ||||||||||||||
| Dietary Intake of Calcium Rich Foods | ||||||||||||||
| Low (<33%) | 146/248 | 1.00 | 80/97 | 1.00 | 135/236 | 1.00 | 91/109 | 1.00 | ||||||
| Medium (33–66%) | 180/261 | 1.18 | (0.88–1.59) | 94/94 | 1.22 | (0.78–1.89) | 162/238 | 1.21 | (0.89–1.66) | 112/117 | 1.10 | (0.73–1.64) | ||
| High (>66%) | 191/216 | 1.39 | (1.00–1.93) | 85/119 | 0.76 | (0.47–1.22) | 177/189 | 1.49 | (1.06–2.11) | 99/146 | 0.73 | (0.47–1.14) | ||
|
|
|
|
|
| ||||||||||
| . | . | |||||||||||||
Dietary effect adjusted for age, sex, study center, BMI, self-reported hypertensive status, and smoking status.
Frequency of dietary intake variables categorized into tertiles based on intake among genotyped controls.
Calcium rich foods based on consumption of cheese, yogurt, and milk.
Main effects adjusted for age, sex, study center, and smoking status.
rs3118538 (IVS4-542C > A) main effects: AC (0.68(0.39–1.18)), AA (0.58(0.34–0.99)), P-trend = .02; AC/AA (0.82(0.67–1.00)).
rs10776909 (IVS1-4732C > T) main effects: CT (0.69(0.42–1.13)), TT (0.62(0.38–1.00)), P-trend = .05; CT/TT (0.86(0.70–1.04)).
*Likelihood Ratio Test.
VDR haplotypes and RCC risk among males before and after stratification by cumulative.
| Low cumulative exposure | Medium cumulative exposure | High cumulative exposure | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male Participants | < |
| > | ||||||||||||||||||
|
| |||||||||||||||||||||
|
| Cases | Controls |
| Cases | Controls | Cases | Controls | Cases | Controls | ||||||||||||
|
| |||||||||||||||||||||
| Haplotypes | % | % | OR | (LCI-UCI) |
| % | % | OR | (LCI-UCI) |
| % | % | OR | (LCI-UCI) |
| % | % | OR | (LCI-UCI) |
| *LRT |
|
| |||||||||||||||||||||
| 5′-rs2254210, rs2853564, rs4760648-3′ | |||||||||||||||||||||
| G-A-T | 39.9 | 43.8 | 1.00 | 44.2 | 41.5 | 1.00 | 38.5 | 42.7 | 1.00 | 37.4 | 46.2 | 1.00 | |||||||||
| A-G-C | 31.7 | 28.3 | 1.27 | (1.03–1.57) |
| 29.7 | 31.0 | 0.93 | (0.63–1.37) | .72 | 31.7 | 28.7 | 1.23 | (0.87–1.74) | .25 | 33.5 | 25.6 | 1.70 | (1.14–2.53) |
| |
| G-A-C | 19.5 | 18.5 | 1.19 | (0.94–1.51) | .16 | 16.9 | 18.0 | 0.84 | (0.52–1.37) | .49 | 22.2 | 17.2 | 1.46 | (0.99–2.16) | .06 | 19.2 | 20.3 | 1.15 | (0.75–1.78) | .52 | |
| G-G-C | 5.7 | 6.6 | 0.97 | (0.67–1.42) | .88 | 5.3 | 7.1 | 0.74 | (0.36–1.50) | .40 | 5.5 | 7.7 | 0.76 | (0.42–1.39) | .38 | 6.6 | 5.3 | 1.83 | (0.88–3.81) | .11 | |
|
|
|
|
|
| |||||||||||||||||
| .06 | |||||||||||||||||||||
Main effects adjusted for age, study center, BMI, self-reported hypertensive status, and smoking status.
Occupational UV effect adjusted for age, study center, BMI, self-reported hypertensive status, smoking status, and dietary intake frequency of vitamin D rich foods.
rs2245210 (IVS3-816G > A) main effects: AG (0.86(0.63–1.18)), GG (0.71(0.52–0.98)), P-trend = .02;
rs2853564 (IVS2-1930A > G) main effects: AG (1.00(0.75–1.33)), GG (0.77(0.58–1.04)), P-trend = .03;
rs4760648 (IVS2-4108C > T) main effects: CT (0.81(0.65–1.00)), TT (0.64(0.48–0.85)), P-trend = .002.
* Likelihood Ratio Test.